Tilray (TLRY) Projected to Post Quarterly Earnings on Tuesday

Tilray (NASDAQ:TLRY) will likely be releasing its earnings data before the market opens on Tuesday, April 8th. Analysts expect Tilray to post earnings of ($0.04) per share and revenue of $213.38 million for the quarter. Tilray has set its FY 2025 guidance at EPS.

Tilray (NASDAQ:TLRY) last released its quarterly earnings results on Friday, January 10th. The company reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.07). Tilray had a negative return on equity of 4.40% and a negative net margin of 30.95%. The firm had revenue of $210.90 million for the quarter, compared to analysts’ expectations of $216.34 million. The firm’s revenue was up 8.7% on a year-over-year basis. On average, analysts expect Tilray to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Tilray Stock Performance

Tilray stock opened at $0.59 on Friday. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.54 and a quick ratio of 1.58. The firm has a market capitalization of $555.28 million, a P/E ratio of -1.97 and a beta of 1.88. Tilray has a 1-year low of $0.55 and a 1-year high of $2.77. The company’s 50-day moving average is $0.80 and its 200 day moving average is $1.23.

Analysts Set New Price Targets

Separately, Canaccord Genuity Group increased their price target on Tilray from $2.00 to $3.00 and gave the stock a “buy” rating in a report on Monday, January 13th.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.